The Asia Pacific transdermal drug delivery system market is expected to reach US$ 1,736.02 million by 2027 from US$ 1,199.69 million in 2019. The market is estimated to grow at a CAGR of 4.9% from 2020 to 2027.
The growth of the market is attributed to increasing prevalence of chronic diseases, growing demand for non-invasive drug delivery devices, and high demand for self-administration of drugs. However, the drug failure and recalls of transdermal drug delivery systems hinder the growth of the market in Asia Pacific.
The Asia Pacific transdermal drug delivery system market is expected to witness significant growth during the forecast period. The growth of the market is expected to be fastest in countries such as China, India, and Australia. The growth of the market in these countries is expected to be fastest due to growing technology, growing geriatric population, increasing prevalence of cardiovascular diseases, and growing demand for non-invasive medical devices. China is the largest market for transdermal drug delivery systems market. The growth of the transdermal drug delivery system market is primarily attributed to the growing technology in China and increasing developments by the market players. The excessive population in China, coupled with the rising prevalence of chronic diseases is offering immense growth opportunities in the transdermal patches and semisolid products for the pain management market. However, considering the geographic and economic operations between Asian countries and China, the countries are expected to witness challenge of COVID-19. The outbreak of disease has badly affected supply chain, and led to shortage of healthcare supplies in the region. Moreover, domestic start-ups backed by international funding have already started witnessing back out from investors putting the development of the products in jeopardy.
Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Asia Pacific Transdermal Drug Delivery System Market Segmentation
By Type
- Transdermal Patches
- Matrix Patches
- Microneedle Patches
- Drug-In-Adhesive Patches
- Reservoir Membrane Patches
- Transdermal Semisolids
- Sprays
- Gels
- Ointments
By Application
•
Cardiovascular Diseases• Central Nervous System Disorders
• Pain Management
• Hormonal Applications
- Transdermal Estrogen Therapy
- Testosterone Replacement Therapy
• Other Applications
By End User
•
Hospitals and Clinics• Home Care Settings
• Other End Users
By Country
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
Company Profiles
- Novartis AG
- Luye Pharma Group
- Mylan N.V.
- GlaxoSmithKline plc
- Hisamitsu Pharmaceutical Co., Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Transdermal Drug Delivery System Market– By Type
1.3.2 Asia Pacific Transdermal Drug Delivery System Market– By Application
1.3.3 Asia Pacific Transdermal Drug Delivery System Market– By End User
1.3.4 Asia Pacific Transdermal Drug Delivery System Market– By Region
2. Transdermal Drug Delivery System Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Transdermal Drug Delivery System – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific
4.3 Expert Opinion
5. Asia Pacific Transdermal Drug Delivery System Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
5.1.3 High Demand for Self-Administration of Drugs
5.2 Market Restraints
5.2.1 Drug Failure and Recalls of Transdermal Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Strategic Activities by the Manufacturers
5.4 Future Trends
5.4.1 Rise in Adoption of Third-Generation Delivery Systems
5.5 Impact Analysis
6. Transdermal Drug Delivery System Market – Regional Analysis
6.1 Asia Pacific Transdermal drug delivery system Market Revenue Forecast And Analysis
7. Transdermal Drug Delivery System Market Analysis – By Type
7.1 Overview
7.2 Transdermal Drug Delivery System Market Revenue Share, by Type, 2019 and 2027 (%)
7.2.1.1 Asia Pacific Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
7.3 Transdermal Patch
7.3.1 Overview
7.3.2 Transdermal Patch: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
7.3.3 Drug-In-Adhesive Patches
7.3.3.1 Overview
7.3.3.2 Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
7.3.4 Matrix Patches
7.3.4.1 Overview
7.3.4.2 Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
7.3.5 Reservoir Membrane Patches
7.3.5.1 Overview
7.3.5.2 Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
7.3.6 Microneedle Patches
7.3.6.1 Overview
7.3.6.2 Microneedle Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Transdermal Semisolids
7.4.1 Overview
7.4.2 Transdermal Semisolids: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3 Gel
7.4.3.1 Overview
7.4.3.2 Gel: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Sprays
7.5.1 Overview
7.5.2 Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Ointments
7.6.1 Overview
7.6.2 Ointments: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
8. Transdermal Drug Delivery System Market – By Application
8.1 Overview
8.2 Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)
8.2.1 Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
8.3 Cardiovascular Diseases
8.3.1 Overview
8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Central Nervous System Disorders
8.4.1 Overview
8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Pain Management
8.5.1 Overview
8.5.2 Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Hormonal Applications
8.6.1 Overview
8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
8.6.3 Transdermal Estrogen Therapy
8.6.3.1 Overview
8.6.3.2 Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
8.6.4 Testosterone Replacement
8.6.4.1 Overview
8.6.4.2 Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
9. Transdermal Drug Delivery System Market – By End User
9.1 Overview
9.2 Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)
9.2.1 Asia Pacific Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
9.5.3 Other End Users: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
10. Transdermal Drug Delivery System Market– Regional Analysis
10.1 Asia Pacific: Transdermal Drug Delivery System Market
10.1.1 Overview
10.1.2 Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 Asia Pacific Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.4 Asia Pacific Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 Asia Pacific Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.6 Asia Pacific Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.7 Asia Pacific Hormonal Application Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.8 Asia Pacific Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 Asia Pacific: Transdermal Drug Delivery Systems Market, by Country, 2019 & 2027 (%)
10.1.10 China: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 China: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 China Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.10.2.1 China Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.10.2.2 China Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.10.3 China Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.10.3.1 China Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.10.4 China Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.11 Japan: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Japan: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Japan Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.11.2.1 Japan Transdermal Patches Market, by Transdermal Patches – Revenue and Forecast to 2027 (USD Million)
10.1.11.2.2 Japan Transdermal Semisolids Market, by Type– Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Japan Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.11.3.1 Japan Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Japan Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.12 India: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.12.1 India: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.12.2 India Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.12.2.1 India Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.12.2.2 India Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.12.3 India Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.12.3.1 India Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.12.4 India Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.13 South Korea: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.13.1 South Korea: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.13.2 South Korea Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.13.2.1 South Korea Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.13.2.2 South Korea Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.13.3 South Korea Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.13.3.1 South Korea Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.13.4 South Korea Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.14 Australia: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.14.1 Australia: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
10.1.14.2 Australia Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.14.2.1 Australia Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.14.2.2 Australia Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.14.3 Australia Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.14.3.1 Australia Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.14.4 Australia Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Transdermal Drug Delivery System Market
11.1 Asia Pacific: Impact assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Novartis AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GlaxoSmithKline plc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MYLAN N.V.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Luye Pharma Group
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hisamitsu Pharmaceutical Co ,Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific Transdermal Drug Delivery System Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific Transdermal Patches Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 6. Asia Pacific Transdermal Semisolids Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 7. Asia Pacific Transdermal Drug Delivery Systems Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 8. Asia Pacific Hormonal Application Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 9. Asia Pacific Transdermal Drug Delivery Systems Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 10. China Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. China Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. China Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 13. China Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 14. China Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. China Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Japan Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Japan Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Japan Transdermal Semisolids Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 19. Japan Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. Japan Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Japan Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 22. India Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. India Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 24. India Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 25. India Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 26. India Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 27. India Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 28. South Korea Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. South Korea Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 30. South Korea Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 33. South Korea Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. Australia Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Australia Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Australia Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 37. Australia Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 38. Australia Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Australia Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 40. Glossary of Terms, Transdermal Drug Delivery System Market
LIST OF FIGURES
Figure 1. Transdermal Drug Delivery System Market Segmentation
Figure 2. Transdermal Drug Delivery System Segmentation – By Region
Figure 3. Asia Pacific Transdermal Drug Delivery System Market Overview
Figure 4. Transdermal Patches Segment Held Largest Share of Transdermal Drug Delivery System Market
Figure 5. China Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific PEST Analysis
Figure 7. Asia Pacific Transdermal Drug Delivery System Market – Revenue Forecast And Analysis – 2019- 2027
Figure 8. Transdermal Drug Delivery System Market Revenue Share, by Type, 2019 and 2027 (%)
Figure 9. Transdermal Patch: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 10. Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Microneedle Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Transdermal Semisolids: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Gel: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Ointments: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)
Figure 19. Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Other Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)
Figure 27. Hospitals and Clinics: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Home Care Settings: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Asia Pacific: Transdermal Drug Delivery System Market, by Key Country – Revenue (2019) (USD Million)
Figure 30. Asia Pacific Transdermal Drug Delivery Systems Market Revenue and Forecast to 2027 (USD Million)
Figure 31. Asia Pacific: Transdermal Drug Delivery Systems Market, by Country, 2019 & 2027 (%)
Figure 32. China: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Japan: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. India: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. South Korea: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Australia: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Impact of COVID-19 Pandemic In Asia-Pacific Country Markets
- Novartis AG
- Luye Pharma Group
- Mylan N.V.
- GlaxoSmithKline plc
- Hisamitsu Pharmaceutical Co., Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Transdermal Drug Delivery System Market
Aug 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Aug 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)